Cite
HARVARD Citation
He, M. et al. (2020). The Predictive Value of Early Changes in 18F‐Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor‐Positive Metastatic Breast Cancer. Oncologist. pp. 927-936. [Online].